Badreddin Edris, Chief Operating Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 39,615 shares at $41.38 ($1.6M) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($1.6M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.40 | 11,772 | $464K | 29.2% |
| 2 | $39.40 | 11,772 | $464K | 29.2% |
| 3 | $40.62 | 4,192 | $170K | 10.7% |
| 4 | $40.62 | 4,192 | $170K | 10.7% |
| 5 | $41.38 | 3,651 | $151K | 9.5% |
| 6 | $41.38 | 3,651 |
| $151K |
| 9.5% |
| 7 | $42.04 | 385 | $16K | 1.0% |
| Total | $40.05 avg | 39,615 | $1.6M | 100% |
| Filing → |
| SWTX | SELL | 2025-02-12 | $1.6M | — | Filing → |
| SWTX | SELL | 2024-12-05 | $1.7M | — | Filing → |
| SWTX | SELL | 2024-09-04 | $1.1M | — | Filing → |